The field of delayed hypersensitivity continues to grow in complexity. One expects that increasing understanding of cell-mediated responses in clinical immunology will lead to greater advances in this field. This review explains and summarizes the pertinent newer concepts of clinical promise.
Get full access to this article
View all access options for this article.
References
1.
GlickB., ChangT. S. and JaapR. G.: The bursa of Fabricius and antibody production. Poultry Sci.35: 224, 1956.
2.
GlickB.: Further evidence for the role of the bursa of Fabricius in antibody production. Poultry Sci.37: 240, 1958.
3.
MillerJ. F. A. P.: Immunological function of the thymus. Lancet2: 748, 1961.
4.
MillerJ. F. A. P., MarshallA. H. E. and WhiteR. C.: The immunological significance of the thymus. Adv. Immunol.2: Ill, 1962.
5.
GoodR. A., DalmassoA. P., MartinezC., ArcherO. K., PierceJ. C. and PapermasterB. W.: The role of the thymus in development of immunologic capacity in rabbits and mice. J. Exp. Med.116: 773, 1962.
6.
MartinezC., KerseyJ., PapermasterB. W. and GoodR. A.: Skin homograft survival in thymectomized mice. Proc. Soc. Exp. Biol. Med.109: 193, 1962.
7.
CooperM. D., PetersonR. D. A. and GoodR. A.: Delineation of the thymic and bursal lymphoid systems in the chicken. Nature (London)205: 143, 1965.
8.
WaksmanB. H.: Delayed hypersensitivity: immunologic and clinical aspects. In Immunobiology, GoodR. A. and FisherD. W., Eds. Stanford, Conn, Sinauer Associates Inc., p. 28.
9.
BloomB. R.: In vitro approaches to the mechanism of cell-mediated immune reactions. Adv. Immunol.13: 101, 1971.
10.
GoodR. A.: Structure-function relations in the lymphoid system. In Clinical Immunobiology, BachF. H. and GoodR. A., Eds. New York, Academic Press, 1972, Vol. 1, p. 1.
11.
LawrenceH. S.: Cellular immunity. In Clinical Immunobiology, BachF. H. and GoodR. A., Eds. New York, Academic Press, 1972, Vol. 1, p. 47.
12.
DavidJ. R. and DavidR. R.: Cellular hypersensitivity and immunity. Inhibition of macrophage migration and lymphocyte mediators. Progr. Allergy16: 300, 1972.
13.
WarrenK. S.: Pathophysiology and pathogenesis of hepatosplenic Schistosomiasis mansoni. Bull. N. Y. Acad. Med.44: 280, 1968.
14.
TurkJ. L. and BrysonA. D. M.: Immunological phenomena in leprosy and related diseases. Adv. Parasit.13: 209, 1971.
15.
PattersonP. Y.: Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med.111: 119, 1960.
16.
FieldE. J. and CasparyE. A.: Is maternal lymphocyte sensitization passed to the child. Lancet2: 337, 1971.
17.
HenneyC. S. and WaldmanR. H.: Cell-mediated immunity shown by lymphocytes from the respiratory tract. Science169: 696, 1970.
18.
DumondeD. C., WolstencroftR. A., PanayiG. S., MatthewM., MorleyJ. and HowsonW. T.: “Lymphokines”: nonantibody mediators of cellular immunity generated by lymphocyte activation. Nature224: 38, 1969.
19.
In vitro methods in cell-mediated immunity. BloomB. R. and GladeP. R., Eds. New York, Academic Press, 1971.
20.
OppenheimJ. J.: Relationship of in vitro lympho-cyte transformation to delayed hypersensitivity in guinea pigs and man. Fed. Proc.27: 21, 1968.
21.
OppenheimJ. J., LeventhalB. G. and HershE. M.: The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J. Immunol.101: 262, 1968.
22.
BloomB. R., JimenzL. and MarcusP. I.: A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J. Exp. Med.132: 16, 1970.
23.
WybranJ., LevinA. S., SpitlerL. E. and FundenbergH. H.: Rosette-forming cells, immunologic deficiency diseases and transfer factor. N. Engl. J. Med.288: 710, 1973.
24.
BloomB. R. and BennettB.: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science153: 80, 1966.
25.
DavidJ. R.: Delayed hypersensitivity in vitro. Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Nat. Acad. Sci. Wash.56: 72, 1966.
26.
RocklinR. E., MeyersO. C. and DavidJ. R.: An in vitro assay for cellular hypersensitivity in man. J. Immunol. 104: 95, 1970.
27.
SøborgM. and BendixenG.: Human lymphocyte migration as a parameter of hypersensitivity. Acta Med. Scand.181: 247, 1967.
28.
LolekhaS., DrayS. and GotoffS. P.: Macrophage aggregation in vitro. A correlate of delayed hypersensitivity. J. Immunol.104: 296, 1970.
29.
WardP. A., RemoldH. G. and DavidJ. R.: Leukotactic factor produced by sensitized lymphocytes. Science163: 1079, 1969.
30.
WardP. A., RemoldH. G. and DavidJ. R.: The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cellular Immunol.1: 162, 1970.
31.
MackanessG. B.: The immunological basis of acquired cellular resistance. J. Exp. Med.120: 105, 1964.
32.
MackanessG. B.: The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med.129: 973, 1969.
33.
MackanessG. B.: The monocyte in cellular immunity. Seminars in Hematology7: 172, 1970.
34.
BloomB. R. and BennettB.: Macrophages and delayed-type hypersensitivity. Seminars in Hematology7: 215, 1970.
35.
Van FurthR., CohnZ. A., HirschJ. G., HumphreyJ. A., SpectorW. G. and LangevoortH. L.: The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull. WHO46: 845, 1972.
36.
SnydermanR., AltmanL. C., FrankelA. and BlaeseR. M.: Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Ann. Intern. Med.78: 509, 1973.
37.
RosenauS. A. and MoonH. D.: Lysis of homologous cells by sensitized lymphocytes in tissue culture. J. Nat. Cancer Inst.27: 471, 1961.
38.
GrangerG. A. and WilliamsT. W.: Lymphocyte cytotoxicity in vitro. Activation and release of a cytotoxic factor. Nature (London)218: 1253, 1968.
39.
RuddleN. H. and WaksmanB. H.: Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. II. Correlation of the in vitro response with skin reactivity. J. Exp. Med.128: 1255, 1968.
40.
GreenJ. A., CooperbandS. R., RutsteinJ. A. and KibrickS.: Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. J. Immunol.105: 48, 1970.
41.
LandsteinerK. and ChaseM. W.: Experiments on transfer of cutaneous sensitivity to simple compounds. Proc. Soc. Exp. Biol. Med.49: 688, 1972.
42.
ChaseM. W.: The cellular transfer of cutaneous hypersensitivity to tuberculin. Proc. Soc. Exp. Med.59: 134, 1945.
43.
ThorD. E.: Delayed hypersensitivity in man. An in vitro correlate and transfer by an RNA extract. Science157: 1567, 1967.
44.
BaramP. and MoskoM. M.: A dialyzable fraction from tuberculin-sensitive human white blood cells capable of inducing tuberculin-delayed hypersensitivity in negative recipients. Immunology8: 461, 1965.
45.
MaddisonS. E., HicklinM. D., ConwayB. P. and KaganI. G.: Transfer factor: delayed hypersensitivity to Schistosoma mansoni and tuberculin in Macaca, mulatta. Science178: 757, 1972.
46.
LawrenceH. S., Al-AskariS., DavidJ. R., FranklinE. C. and ZweimanB.: Transfer of immunological information in humans with dialysates of leukocyte extracts. Trans. Amer. Ass. Phys.76: 84, 1963.
47.
LawrenceH. S.: Transfer factor. Adv. Immunol.11: 195, 1969.
48.
SchulkindM. L., AdlerW. H., AltermeierW. A.III and AyoubaE. M.: Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell. Immunol.3: 606, 1972.
49.
PabstH. F. and SwansonR.: Successful treatment of candidiasis with transfer factor. Br. Med. J.2: 442, 1972.
50.
KirkpatrickC.H., RichR. R. and SmithT. K.: Effect of transfer factor on lymphocyte function in anergic patients. J. Clin. Invest.51: 2948, 1972.
51.
LevinA. S., SpitlerL. E., StitesD. P. and FudenbergH. H.: Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc. Natl. Acad. Sci. USA67: 821, 1970.
52.
BullockW. E., FieldsJ. P. and BrandissM. W.: An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. N. Engl. J. Med.287: 1053, 1972.
53.
LawrenceH. S.: Immunotherapy with transfer factor. N. Engl. J. Med.287: 1092, 1972.
54.
BrandesL. J., SaltonD. A. G. and WiltshawE.: New approach to immunotherapy of melanoma. Lancet2: 293, 1971.
55.
SpitlerL. E., LevinA. S., BloisM. S., EpsteinW., FudenbergH. H., HellstromI. and HellstromK. E.: Lymphocyte responses to tumor-specific antigens in patients with malignant melanoma and results of transfer factor therapy. J. Clin. Invest.51: 92 (Abstract), 1972.
